lentiviral vector plko 1 shrna control shctrl (Addgene inc)
96
Structured Review
Addgene inc
lentiviral vector plko 1 shrna control shctrl
Lentiviral Vector Plko 1 Shrna Control Shctrl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 384 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+shrna+shctrl/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/pm41596422-229-0-6
Average 96 stars, based on 384 article reviews
Lentiviral Vector Plko 1 Shrna Control Shctrl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 384 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+shrna+shctrl/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/pm41596422-229-0-6
Average 96 stars, based on 384 article reviews
lentiviral vector plko 1 shrna control shctrl - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Negative Control:Article Title: ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer. Article Snippet: Background Gemcitabine (GEM)-based chemotherapy regimens is widely used in bladder cancer (BC) patients.. However, GEM resistance may occur and result in treatment failure and disease progression.. A disintegrin and metalloprotease 12 (ADAM12) plays a critical role in many cancers. shRNA:Article Title: ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer. Article Snippet: Background Gemcitabine (GEM)-based chemotherapy regimens is widely used in bladder cancer (BC) patients.. However, GEM resistance may occur and result in treatment failure and disease progression.. A disintegrin and metalloprotease 12 (ADAM12) plays a critical role in many cancers. |